Deep Track Capital »

EXACT Sciences Corporation shares owned by Deep Track Capital

Quarter-by-quarter ownership of EXACT Sciences Corporation (EXAS) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in EXACT Sciences Corporation

Tip: Access up to 7 years of quarterly data

All positions including EXACT Sciences Corporation held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in EXACT Sciences Corporation by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $55M 1.0M 54.71

More positions owned by Deep Track Capital

Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Akero Therapeutics (AKRO)
Apellis Pharmaceuticals (APLS)
Tarsus Pharmaceuticals (TARS)
Immunovant (IMVT)
Dynavax Technologies Corp Com New (DVAX)
Ocular Therapeutix (OCUL)
89bio (ETNB)
Structure Therapeutics Sponsored Ads (GPCR)
Miragen Therapeutics (VRDN)
Protagonist Therapeutics (PTGX)
Axsome Therapeutics (AXSM)
Vaxcyte (PCVX)

View all positions for Deep Track Capital

Top funds holding EXACT Sciences Corporation

FMR
Vanguard Group
Capital World Investors
BlackRock
Wellington Management Company
State Street Corporation
Ameriprise Financial
Citadel Advisors
Massachusetts Financial Services
Geode Capital Management
Mackenzie Financial
Holocene Advisors
Canada Pension Plan Investment Board
William Blair Investment Management
Champlain Investment Partners

View all funds holding EXACT Sciences Corporation